Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Gene Silencing/Gene Editing » Texas A&M's Keerti Rathore on Using RNAi to Build an Edible Cottonseed

Texas A&M's Keerti Rathore on Using RNAi to Build an Edible Cottonseed

Nov 30, 2006
Premium
Name: Keerti Rathore
 
Position: Associate professor/director, Institute for Plant Genomics & Biotechnology, Texas A&M University
 
Background:Assistant professor, Institute for Plant Genomics & Biotechnology, Texas A&M — 1997-2003
Research scientist, Crop Biotechnology Center, Texas A&M — 1995-1997

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

'Glaring' Opening at FDA

The New York Times writes that the unfilled top spot at the US Food and Drug Administration is "glaring."

No New Concerns

Reuters reports that no serious safety concerns have been identified in the first month of SARS-CoV-2 vaccinations in the US.

Boost to Surveillance

The Canadian COVID-19 Genomics Network aims to increase its genomic surveillance of emerging SARS-CoV-2 strains, the Canadian Press reports.

PLOS Papers on Pharmacogenes in Hong Kong, Defective Viral Genomes, Brazilian Breast Cancer

In PLOS this week: actionable pharmacogenetic variants in Hong Kong population, role of defective viral genomes, and more.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Mar
09
Featured Webinar

Implementation of Whole-Exome and Virtual Panel Testing for Rare Disease at a Children’s Hospital

Sponsored by
Fabric Genomics

The growth of next-generation sequencing (NGS) testing presents both opportunities and challenges for clinical, informatics, and laboratory teams. 

Mar
11
Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

Sponsored by
Foundation Medicine

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

What's Popular?

In Gene Silencing/Gene Editing

  1. Cytosine Base Editors Allow Scientists to Study Function of Variants at Scale

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.